The third edition of this critically acclaimed book has updated and expanded the survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. Internationally renowned editors and contributors explore the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors.
Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Third Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by leaders of the field.
Table of Contents
Renal Cell Carcinoma: Molecular Targets & Clinical Applications, 3rd Edition
Editors: Ronald M. Bukowski, M.D., Robert Figlin, M.D., Robert Motzer, M.D.
?
?
Ch. 1: Targeted Therapy for Metastatic Renal Cell Carcinoma : the First Ten Years
Ronald M. Bukowski, M.D., Robert Figlin, M.D., Robert Motzer, M.D.
?
Ch. 2: RCC: Pathologic and Molecular assessment of Targets
?
??????????? Ferran Algaba, M.D.
?
Ch. 3: Targeted Therapy for Metastatic Renal Cell Carcinoma : the First Ten Years
??????????? Stephen M. Keefe, M.D., W. Kimryn Rathmell, M.D., Ph.D., Katherine L. Nathanson, M.D.
?
Ch. 4: VHL and HIF in clear cell Renal Cell Carcinoma: Molecular Abnormalities and Potential Clinical Applications
?